Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Genetic drivers and clinical consequences of mosaic chromosomal alterations in 1 million individuals

Submitted by Frida Mäkelä on Fri, 03/07/2025 - 10:29
  • Read more about Genetic drivers and clinical consequences of mosaic chromosomal alterations in 1 million individuals

Gene discovery and pleiotropic architecture of Chronic Pain in a Genome-wide Association Study of >1.2 million Individuals

Submitted by Frida Mäkelä on Fri, 03/07/2025 - 10:23
  • Read more about Gene discovery and pleiotropic architecture of Chronic Pain in a Genome-wide Association Study of >1.2 million Individuals

Genetic liability to psoriasis predicts severe disease outcomes

Submitted by Frida Mäkelä on Fri, 03/07/2025 - 10:16
  • Read more about Genetic liability to psoriasis predicts severe disease outcomes

Understanding the Comorbidities Among Psychiatric Disorders, Chronic Low Back Pain, and Spinal Degenerative Disease Using Observational and Genetically Informed Analyses

Submitted by Frida Mäkelä on Fri, 03/07/2025 - 10:10
  • Read more about Understanding the Comorbidities Among Psychiatric Disorders, Chronic Low Back Pain, and Spinal Degenerative Disease Using Observational and Genetically Informed Analyses

Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations

Submitted by Frida Mäkelä on Fri, 03/07/2025 - 09:47
  • Read more about Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations

Cardiovascular diseases and risk of dementia in the general population

Submitted by Frida Mäkelä on Fri, 03/07/2025 - 09:27
  • Read more about Cardiovascular diseases and risk of dementia in the general population

Genetic structure of the healthy donor effect

Submitted by Frida Mäkelä on Thu, 03/06/2025 - 16:39
  • Read more about Genetic structure of the healthy donor effect

Prebiotic xylo-oligosaccharides for alleviation of hepatic steatosis: Results from a four-month dietary intervention and determinants of response

Submitted by Frida Mäkelä on Thu, 03/06/2025 - 16:33
  • Read more about Prebiotic xylo-oligosaccharides for alleviation of hepatic steatosis: Results from a four-month dietary intervention and determinants of response

Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies

Submitted by Frida Mäkelä on Thu, 03/06/2025 - 16:23
  • Read more about Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy-Related Cardiomyopathies

Mendelian randomization analyses uncover causal relationships between brain structural connectome and risk of psychiatric disorders

Submitted by Frida Mäkelä on Thu, 03/06/2025 - 16:19
  • Read more about Mendelian randomization analyses uncover causal relationships between brain structural connectome and risk of psychiatric disorders

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • Current page 143
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement